Loeb S, Zhou Q, Siebert U, Rochau U, Jahn B, Mühlberger N, Carter HB, Lepor H, Braithwaite RS.
“Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions”.
European Urology 2017 Aug 22 epub. PMID: 28844371
Link: https://www.ncbi.nlm.nih.gov/pubmed/28844371
We designed a Markov model showing that active surveillance extends life more than watchful waiting, particularly for men with higher risk features, but this is partly offset by decrements in quality of life from delayed treatment. Trade-offs about the intensity of surveillance should be discussed with patients.